GO
| HSI1 | 23,211.81 | 0.00 | -- |
| HSCEI1 | 7,802.09 | 0.00 | -- |
| Back Zoom + Zoom - Block Traded | |
|
2026-10-26 19:06:39 CLSA published a research report stating that the US Treasury Department proposed on October 23 to include biotechnology in the prohibited technology scope under the Comprehensive Outbound Investment National Security Act (COINS), with final rules expected to be announced before March 13, 2027. The broker believes that based on the current draft, there will be no material impact on China's biotechnology licensing model, as most transactions still remain at the asset level, largely eliminating cliff-edge risks. The broker noted that the proposed scope is broad, covering biotechnology activities including drug compounds. The greater risk lies in equity investment cooperation models involving US capital, which may face stricter scrutiny or even restrictions. The broker believes the current draft already represents the broadest coverage version, while the final regulations may still undergo substantial revisions. The consultation period will last until December 7. (ad/u)~ AASTOCKS Financial News Website: www.aastocks.com This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. | |